OmanDocSign in

Curriculum · Gynecology / Women's Health / Infertility / Perinatal Care / Birth Spacing

Infertility: initial evaluation of a couple failing to conceive

What it is

Infertility is the inability to conceive after one year of regular and unprotected intercourse, and after 6 months in women aged over 35 years. Another page states the same rule as the inability of a sexually active, non-contracepting couple to achieve pregnancy in one year.

Evaluation begins earlier, after 6 months of regular unprotected intercourse, when the woman is over 40 years, has an irregular cycle, has had sexually transmitted diseases, or has cancer.

Causes and risk

The history and examination cover both of the couple.

In the woman: ovulatory problems, pelvic adhesions, tubal blockage, hyperprolactinemia, leiomyoma, endometriosis, advanced age, and a detailed history of coitus and its frequency.

The causes in the female are set out by the part at fault. The ovulatory ones are PCOS, gonadal agenesis, that is Turner syndrome, ovarian cancer, and hypothalamic and pituitary dysfunction such as Sheehan syndrome. The tubal ones are PID and endometriosis. The uterine ones are congenital - septate uterus, bicornuate uterus, uterine didelphys, that is 2 uterus, and Mullerian agenesis - or acquired: submucosal fibroid, adenomyosis, polyp, Asherman syndrome and endometritis. The cervical ones are a low estrogen giving a thick mucus so sperm cannot pass, and cervical stenosis.

In the man: congenital and chromosomal disease such as Klinefelter's, obesity, endocrinopathy, drugs such as androgens, tumor, vascular disease, infiltrative disease, infection, and chemo or radio exposure.

How it is diagnosed

The basic evaluation of the infertile couple is history and examination, semen analysis, a test of ovulation, a test for tubal patency, and TVS.

In the woman:

The hysterosalpingogram is done in the first half of the cycle, the follicular phase, up to day 14. Its complications are four: infection, allergy, embolization and intravasation.

In the man, semen analysis is the initial investigation. The reference values are ejaculate volume 1.5 ml, pH 7.2, sperm concentration 15 x 10^6 spermatozoa/ml, total sperm number 39 x 10^6 spermatozoa per ejaculate, percentage motility 40%, forward progression 32%, and normal morphology 4%. The timing of that progesterone is the point of the question. Serum progesterone is measured on day 21 of the cycle and is abnormal below 3 ng/ml, but day 21 belongs to a 28 day cycle; the rule written beside it is the cycle length minus 7, so a patient with a regular cycle of 35 days has her progesterone measured at day 28. The other ways of showing ovulation are basal body temperature, urinary LH with follicular monitoring, and an endometrial biopsy done 1 week prior to the expected menses, in the luteal phase: a secretory endometrium means progesterone is there and ovulation occurred, a proliferative endometrium means no progesterone and anovulation. Ovarian reserve is a separate question, and the best test for it is serum AMH, the anti-mullerian hormone, a direct reflection of the residual ovarian pool, where normal is above 1 ng/ml and a low value indicates poor reserve; the day 3 tests say the same thing, with inhibin low, FSH above 10 IU/L, estradiol above 80 pg/ml, and an antral follicle count under 4 in both ovaries. For tubal patency the hysterosalpingography is done post-menstrual, on day 5-11 and best on day 10, and if it shows a block the next step is laparoscopy and hysteroscopy.